Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.124.80 CHF
Change Today -1.70 / -1.34%
Volume 585.1K
As of 11:43 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Jacobi

Director and Chairman of Finance & Audit Committee, Actelion Ltd.
AgeTotal Calculated CompensationThis person is connected to 33 board members in 5 different organizations across 6 different industries.

See Board Relationships


Dr. Michael Jacobi has been an Independent Corporate Consultant Since 2007. Dr. Jacobi served as the Chief Financial Officer of Ciba Holding, Inc. from 1997 to March 2007. He was responsible for Treasury, Mergers and Acquisitions (M&A), Investor Relations, Control and Information Management. He served as Group Controller of Ciba-Geigy in 1990 where he had been responsible for CIBA Specialty Chemicals Holding Inc.'s overall corporate financial accounting and reporting. ...

Read Full Background

Corporate Headquarters*

Gewerberstrasse 16
Allschwil, Basel-Landschaft 4123


Phone: 41 61 565 65 65
Fax: 41 61 565 65 00

Board Members Memberships*

Non-Executive Director and Chairman of Audit Committee
Director and Chairman of Audit Committee
Director and Chairman of Finance & Audit Committee


Unknown/Other Education
Universität St. Gallen
Doctorate 1979
Universität St. Gallen
Unknown/Other Education
Harvard Business School
Unknown/Other Education
University of Washington
Doctorate 1979
University of St.Gallen , Washington D.C

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash CompensationSFr.222,000
Total Calculated CompensationSFr.222,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATLN:VX SFr.124.80 CHF -1.70


Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
Robert W. Duggan Chairman and Chief Executive Officer
Pharmacyclics Inc.
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACTELION LTD-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at